1-3 of 3
Elena Usacheva, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Tatiana Ionova, DSc, Natalia Bulieva, MD, Anatoly Golenkov, MDProf, Taras Gritsenko, MD, Lilia Kozlova, MD Prof, Galina Kuchma, MD PhD, Elza Lomaia, MD, Elena Machulaytene, MD, Tatiana Nikitina, PhD, Natalia Novitskaya, MD PhD, Elena Usacheva, MD PhD, Tatiana Shneider, MD, Elena Trifonova, MD PhD, Olga Vinogradova, MD PhD, Anna Zinkovskaya
Journal: Blood
Blood (2017) 130 (Supplement 1): 2181.
https://doi.org/10.1182/blood.V130.Suppl_1.2181.2181
Published: 2017
Journal Articles

Patient-Reported Outcomes in Myelofibrosis Patients Help to Identify Patients' Needs

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Elza Lomaia, MD PhD, Alexandr Myasnikov, MD PhD, Tatyana Pospelova, MD PhD, Andrey Evseev, MD PhD, Taras Gritsenko, MD PhD, Anna Lyamkina, MD PhD, Elena Machulaytene, MD PhD, Elena Usacheva, MD PhD, Anna Rodionova, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5198.
https://doi.org/10.1182/blood.V126.23.5198.5198
Published: 2015
Journal Articles

Outcomes of Second-Line Treatment By Dasatinib in Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia Patients with and without Comorbidities

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Galina Kuchma, MD PhD, Elza Lomaia, MD PhD, Tatyana Shnaider, MD PhD, Elena Usacheva, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5147.
https://doi.org/10.1182/blood.V126.23.5147.5147
Published: 2015